Boston joins resorbable stent market with Synergy CE mark
This article was originally published in Clinica
Executive Summary
Boston Scientific has joined Abbott in the resorbable stent market after getting the CE mark go-ahead for its fourth-generation SYNERGY drug-eluting stent (DES).